[go: up one dir, main page]

Lane et al., 1982 - Google Patents

Serological and biochemical analysis of the PlA1 alloantigen of human platelets

Lane et al., 1982

Document ID
984030343404681548
Author
Lane J
Brown M
Bernstein I
Wilcox P
Slichter S
Nowinski R
Publication year
Publication venue
British Journal of Haematology

External Links

Snippet

A solid phase platelet antibody assay has been developed which rapidly and sensitively detects PlA1 antibodies. The three‐step assay is performed by:(1) adhering platelets to the wells of a microtitre plate,(2) incubating the platelets with test serum, and (3) adding …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/536—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Similar Documents

Publication Publication Date Title
Hašková et al. Simple method of circulating immune complex detection in human sera by polyethylene glycol precipitation
Stobo et al. In vitro studies of inflammatory bowel disease: surface receptors of the mononuclear cell required to lyse allogeneic colonic epithelial cells
Mueller-Eckhardt Idiopathic thrombocytopenic purpura (ITP): clinical and immunologic considerations
Boizard et al. Lek^ a, a New Platelet Antigen Absent in Glanzmann’s Thrombasthenia
Berkel et al. Clinical and immunological studies in a case of selective complete C1q deficiency
Gupta et al. Circulating IgG complexes in primary biliary cirrhosis. A serial study in forty patients followed for two years
Kao Plasma and platelet HLA in normal individuals: quantitation by competitive enzyme-linked immunoassay
Mueller‐Eckhardt et al. Neonatal alloimmune thrombocytopenia due to fetomaternal Zwb incompatibility
Bordin et al. Maternal immunization to Gov system alloantigens on human platelets
Greipp et al. Platelet to leukocyte adherence phenomena associated with thrombocytopenia
Jepson et al. Panhypoplasia of the bone marrow. I. Demonstration of a plasma factor with anti-erythropoietin-like activity
Mayne et al. Rh immunization by the partial D antigen of category DVa
US5773232A (en) Methods for measurement of lymphocyte function
Koppi et al. The cellular mechanism of leukocyte adherence inhibition
Vyas et al. Intrauterine isoimmunization caused by maternal IgA crossing the placenta
Lane et al. Serological and biochemical analysis of the PlA1 alloantigen of human platelets
Von dem Borne et al. IgG4 autoantibodies against erythrocytes, without increased haemolysis: a case report
JPH03500087A (en) Antibody-binding platelet immunoassay
JP2803824B2 (en) Cell surface antigen detection method
Slichter Post‐transfusion purpura: response to steroids and association with red blood cell and lymphocytotoxic antibodies
Juji et al. Mixed agglutination with platelets
Steward et al. Circulating antigen-antibody complexes in onchocerciasis
Taaning et al. Graft‐derived anti‐HPA‐2b production after allogeneic bone‐marrow transplantation
Yam et al. Platelet crossmatch tests using radiolabelled staphylococcal protein A or peroxidase anti‐peroxidase in alloimmunized patients
Aarli Binding of γ-globulin fragments to muscle tissue